---
schema_version: "secwatch.filing_event.v1"
accession: "0000313616-23-000004"
form_type: "8-K"
ticker: "DHR"
cik: "0000313616"
company_name: "DANAHER CORP /DE/"
filed_at: "2023-01-18T23:59:59+00:00"
generated_at: "2026-06-20T14:17:22.835154+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Danaher splits Life Sciences into Biotechnology and Life Sciences segments, effective Q4 2022

## Summary
- New four-segment structure: Biotechnology, Life Sciences, Diagnostics, Environmental & Applied Solutions.
- Former Life Sciences segment divided due to growth differences; change reflected retrospectively from Q4 2022.
- Unaudited recast historical financial data posted at danaher.com under 'Financial Reports'.
- Diagnostics and Environmental & Applied Solutions segments unchanged.
- Segments marketed under brands including CYTIVA, PALL, BECKMAN COULTER, SCIEX, and others.

## SEC filing metadata
- accession: 0000313616-23-000004
- form_type: 8-K
- ticker: DHR
- cik: 0000313616
- company_name: DANAHER CORP /DE/
- filed_at: 2023-01-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313616/000031361623000004/0000313616-23-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313616/000031361623000004/dhr-20230118.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000313616-23-000004
- JSON: https://secwatch.observer/filing/0000313616-23-000004.json
- Plain text: https://secwatch.observer/filing/0000313616-23-000004.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.